Twin Capital Management Inc Edwards Lifesciences Corp Transaction History

Twin Capital Management Inc

$787 Million
Q1 2024

A detailed history of Twin Capital Management Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Twin Capital Management Inc holds 9,624 shares of EW stock, worth $899,651. This represents 0.12% of its overall portfolio holdings.

Number of Shares

9,624

Previous 9,699 0.77%

Holding current value

$899,651

Previous $739,000 24.36%

% of portfolio

0.12%

Previous 0.1%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$72.54 - $95.56 $5,440 - $7,167	-75 Reduced 0.77%	9,624 $919,000
Q4 2023 Jan 31, 2024	BUY	$61.71 - $77.76 $156,249 - $196,888	2,532 Added 35.33%	9,699 $739,000
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $50,505 - $68,074	-729 Reduced 9.23%	7,167 $496,000
Q2 2023 Aug 07, 2023	SELL	$81.41 - $94.33 $14,735 - $17,073	-181 Reduced 2.24%	7,896 $744,000
Q1 2023 May 08, 2023	SELL	$74.26 - $84.51 $26,659 - $30,339	-359 Reduced 4.26%	8,077 $668,000

Q4 2022 Jan 31, 2023	SELL	$68.3 - $87.44 $1,775 - $2,273	-26 Reduced 0.31%	8,436 $629,000
Q3 2022 Oct 21, 2022	BUY	$82.37 - $107.29 $41,185 - $53,645	500 Added 6.28%	8,462 $699,000
Q2 2022 Aug 02, 2022	SELL	$86.5 - $128.27 $8,650 - $12,827	-100 Reduced 1.24%	7,962 $757,000
Q4 2021 Feb 07, 2022	SELL	$106.37 - $130.68 $64,247 - $78,930	-604 Reduced 6.97%	8,062 $1.04 Million
Q3 2021 Oct 29, 2021	BUY	$102.91 - $122.75 $8,232 - $9,820	80 Added 0.93%	8,666 $981,000
Q2 2021 Aug 09, 2021	BUY	$83.84 - $104.76 $219,996 - $274,890	2,624 Added 44.01%	8,586 $889,000
Q1 2021 May 06, 2021	SELL	$78.68 - $90.67 $320,227 - $369,026	-4,070 Reduced 40.57%	5,962 $499,000
Q4 2020 Feb 11, 2021	SELL	$71.69 - $91.23 $25,736 - $32,751	-359 Reduced 3.45%	10,032 $915,000
Q3 2020 Nov 05, 2020	SELL	$67.19 - $87.44 $20,492 - $26,669	-305 Reduced 2.85%	10,391 $829,000
Q2 2020 Aug 04, 2020	BUY	$57.54 - $76.95 $325,043 - $434,690	5,649 Added 111.93%	10,696 $739,000
Q1 2020 Apr 29, 2020	BUY	$52.41 - $81.0 $4,716 - $7,290	90 Added 1.82%	5,047 $952,000
Q4 2019 Jan 29, 2020	SELL	$71.7 - $82.09 $8,604 - $9,850	-120 Reduced 2.36%	4,957 $1.16 Million
Q3 2019 Oct 28, 2019	SELL	$61.55 - $75.43 $19,080 - $23,383	-310 Reduced 5.75%	5,077 $1.12 Million
Q2 2019 Aug 01, 2019	SELL	$55.74 - $64.41 $869,153 - $1 Million	-15,593 Reduced 74.32%	5,387 $995,000
Q1 2019 May 03, 2019	SELL	$47.89 - $64.05 $2,394 - $3,202	-50 Reduced 0.24%	20,980 $4.01 Million
Q3 2018 Nov 08, 2018	BUY	$45.7 - $58.03 $961,071 - $1.22 Million	21,030 New	21,030 $3.66 Million
Q4 2017 Jan 29, 2018	SELL	$33.79 - $39.39 $1.69 Million - $1.97 Million	-50,060 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$36.29 - $38.83 $301,207 - $322,289	8,300 Added 19.88%	50,060 $5.47 Million
Q2 2017 Aug 07, 2017	BUY	N/A	41,760	41,760 $4.94 Million

Others Institutions Holding EW

# of Institutions

1,377

Shares Held

454M

Call Options Held

3.86M

Put Options Held

3.32M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $57.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Twin Capital Management Inc with notifications on news.

Account

Twin Capital Management Inc Edwards Lifesciences Corp Transaction History